In a jam-packed hearing room, Sen. Bernie Sanders pressed CEOs with familiar que...
Gilead will no longer develop magrolimab, a treatment targeting the “don’t eat m...
Boehringer has entered a strategic collaboration with CBmed to expedite the tran...
AstraZeneca has reported a significant 81% rise in profit after tax, reaching $5...
BioNTech has entered into a strategic partnership with Autolus Therapeutics to p...
The Phase I trial for evaluating Hemogenyx’s CAR-T therapy to treat acute myeloi...
Pharma CEOs defended their high prescription drug costs, stating that the curren...
Nippon will pay $10m upfront and up to $275m in milestone-based payments for the...
Philips' has recalled a number of high profile medical devices in recent years, ...
Novo Nordisk’s plans to buy Catalent has raised objections related to the risk o...
The survey by CRO Worldwide Clinical Trials shows that pharma and biotechs favou...
Janssen has filed a Type II extension of indication application with the EMA see...
The FDA estimates that taking menthol cigarettes off the market would save up to...
A neurologist explains why knowing about CTE doesn’t keep Americans from watchin...
Private equity investment in health care ramped up in three sectors: cardiology,...
It’s not uncommon for scientists to disagree over authorship. But it’s highly un...
